Series B Raise Timeline and Milestones for US Startups

    US startups typically raise Series B funding 12-24 months after Series A, targeting $15M-$60M at $100M median pre-money valuations. Requires $5-10M ARR with 15-20% monthly growth and proven unit economics.

    ByDavid Chen
    ·10 min read
    Editorial illustration for Series B Raise Timeline and Milestones for US Startups - venture-capital insights

    Series B Raise Timeline and Milestones for US Startups

    Most US startups raise Series B funding 12-24 months after closing their Series A round, targeting $15M-$60M at median pre-money valuations around $100M. According to Sheetventure (2026), companies need $5-10M in annual recurring revenue with 15-20% monthly growth and proven unit economics to secure institutional Series B capital.

    Angel Investors Network provides marketing and education services, not investment advice. Consult qualified legal, tax, and financial advisors before making investment decisions.

    What Separates Series A from Series B Funding?

    Series A validates product-market fit. Series B proves you can scale it profitably.

    Series A investors write $2M-$15M checks betting on potential and vision. Series B investors deploy $15M-$60M betting on proven metrics and operational efficiency, according to GrowthList data tracking 7,100+ Series B companies (2026). Series A typically dilutes founders 15-30%. Series B takes another 10-20%, but median pre-money Series B valuations sit at $102.8M for primary rounds and $80.8M for bridge rounds, per Carta benchmarks.

    The revenue bar jumps from $1M-$2M ARR at Series A to $5M-$10M ARR at Series B. You're proving the go-to-market motion is repeatable at scale. Series B investor focus shifts to unit economics: Can you acquire customers profitably? What's your burn multiple? How long until you're default alive?

    How Long Between Series A and Series B?

    The standard timeline is 12-24 months, but that's not a rule—it's an outcome. Companies that raise Series B in 12 months crushed their growth targets and had inbound interest before opening the round. Companies that take 24 months faced market headwinds, burned through capital faster than expected, or needed extra runway to prove the business model.

    What actually determines your timeline: when you hit the metrics. If you raised Series A at $3M ARR projecting $10M ARR in 18 months, you can't raise Series B at $6M ARR just because 18 months passed. According to Sheetventure (2026), recent market conditions have compressed timelines for top performers while extending them for companies that miss projections.

    What Revenue Milestones Do Series B Investors Expect?

    $5M-$10M ARR is the entry point, but investors want consistent monthly growth of 15-20% in that revenue base. A company at $8M ARR growing 5% monthly looks weaker than one at $6M ARR growing 25% monthly.

    Net revenue retention above 110% separates winners. If existing customers expand revenue 10%+ annually through upsells and expansion, you've proven pricing power. Gross margins matter more at Series B—software companies need 70%+, hardware 40-50%. The path to profitability becomes real: investors want a credible plan to reach break-even within 12 months of closing Series B.

    Which Markets Are Series B Investors Targeting in 2026?

    AI and B2B software dominate. According to GrowthList, the top sectors for Series B funding in 2026 are AI/B2B software, biotech/healthcare, fintech, and climate tech—representing roughly 70% of deployed capital.

    Recent Series B raises from Fundraise Insider (2026) show this concentration:

    • Expo (Palo Alto, CA) — information technology & services
    • Wealth.com (Tempe, AZ) — financial services
    • Turion Space (Irvine, CA) — defense & space
    • Bluefish (New York, NY) — information technology & services
    • Mintlify (San Francisco, CA) — information technology & services
    • Neomorph (San Diego, CA) — research/biotech
    • Luminai (San Francisco, CA) — information technology & services
    • Sidewinder Therapeutics (San Diego, CA) — research/biotech
    • Patlytics (San Francisco, CA) — information technology & services

    Geography concentrates in the United States, United Kingdom, India, China, Germany, and Australia. Within the US, California dominates—San Francisco, San Diego, Palo Alto, and Irvine appear repeatedly. Climate tech and biotech represent contrarian bets for investors with patient capital as software multiples compress.

    What Team and Operational Milestones Matter at Series B?

    By Series B, investors expect specialized roles and middle management. Your early generalists need clear domains. You should have heads of sales, marketing, product, engineering, and operations reporting to the CEO. Successful Series B companies typically 3-5x headcount between A and B while maintaining or improving revenue per employee.

    Process and systems separate Series B from Series A: real CRM with pipeline visibility, defined sales plays, onboarding processes, engineering sprint methodologies, and product roadmaps. Board composition matters—you should have 1-2 independent board members beyond investors and founders.

    How Does Series B Due Diligence Differ from Earlier Rounds?

    Series B diligence is forensic. Series A diligence is directional.

    At Series B, investors have 12-24 months of financial statements to audit. They'll model your unit economics six ways, interview your top 10 customers, and dig into churn cohorts. Financial diligence expands dramatically: monthly revenue by cohort, CAC by channel, sales cycle length by deal size, and net revenue retention by customer segment.

    Competitive landscape becomes real. Investors want win/loss analysis, competitive tear-downs, and differentiation proof. Reference calls multiply—investors talk to current customers, churned customers, former employees, and investors who passed on Series A.

    What Are the Biggest Pitfalls That Kill Series B Raises?

    Premature scaling kills more Series B attempts than any other mistake. Companies hire aggressively and burn through capital before proving the core business scales efficiently. The 1 in 3 survival rate from Series A to Series B, cited by Sheetventure (2026), reflects execution failures—companies that couldn't translate early traction into repeatable growth.

    Founder misalignment becomes obvious during diligence. If co-founders disagree on strategy, investors smell it. Market timing risk increases between A and B—valuations compress and investor appetite shifts. Weak board management surfaces if Series A investors aren't making intros or helping refine the narrative. Cap table issues that seemed minor at Series A—messy equity splits, excessive advisor grants—become deal-breakers.

    How Should Startups Time Their Series B Fundraise?

    Start conversations 6-9 months before you need capital. Close 3-6 months before you run out of runway.

    The worst time to raise is when you desperately need cash. The best time is when you don't strictly need to—you've got 12+ months runway, revenue is accelerating, and you're raising to capitalize on momentum. Market conditions matter more at Series B. In 2025, GrowthList tracked $54.2 billion deployed across 7,100+ Series B deals, but if that drops 30% year-over-year, the bar for getting funded rises.

    Avoid closing in July/August or late November/December—partner availability drops and deals stretch from 6-8 weeks to 12+ weeks.

    What's the Relationship Between Series B and Alternative Capital Formation?

    Regulation Crowdfunding and Reg A+ offerings sit at the opposite end of the capital spectrum from institutional Series B rounds, but ecosystems are intersecting.

    Companies like BackerKit, which recently opened a $1M RegCF offering, represent a different path—using community-led capital formation to engage retail investors rather than raising traditional Series B rounds. The Dividends RegCF campaign targeting $10M shows how companies use retail capital to bridge between institutional rounds.

    The trade-off: RegCF caps at $5M per 12-month period. Reg A+ allows up to $75M but requires extensive SEC filing. Series B rounds routinely raise $30M-$60M with less regulatory burden but significant equity dilution and board control implications.

    What Does a Strong Series B Pitch Deck Actually Contain?

    Series B decks are metrics documents, not vision documents. Lead with the number that matters most: revenue growth rate, customer count, or market share. Put it on slide 2.

    The problem/solution slides shrink to one slide maximum. Financial performance gets 40% of the deck: revenue trends, cohort retention, unit economics, burn rate, and path to profitability. Competitive positioning requires real data—win/loss records, head-to-head comparisons, customer testimonials calling out why they chose you over alternatives.

    Go-to-market execution proof: show the sales funnel, conversion rates by stage, average deal size trends, and sales cycle compression. Team slides need depth—highlight relevant scaling experience. Use of funds needs precision: "Add 15 AEs across three new verticals, invest $3M in enterprise features, expand marketing to ABM motion targeting Fortune 500."

    How Do Term Sheets Differ Between Series A and Series B?

    Series B term sheets introduce protective provisions that didn't exist in Series A. According to Sheetventure (2026), Series B rounds "often add stronger anti-dilution rules to protect investors." Participation rights become more common—Series B investors might negotiate for 1x participating preferred, reducing founder returns in modest exits.

    Board seats multiply. Your Series A lead took one seat; Series B lead wants one too. Now you've got two investor board seats, 1-2 founder seats, and 1-2 independent seats. Pro-rata rights and information rights expand—monthly financial reporting, annual budgets, notification of material events.

    Option pool expansions often accompany Series B, increasing to 15-20% of fully diluted shares. The real trap: liquidation preference stacking. If Series A was $10M at 1x and Series B is $30M at 1x, investors get $40M back before founders see anything. In a $50M exit, founders get $10M. In a $35M exit, founders get zero.

    How Do You Build Investor Pipeline for Series B?

    Warm intros beat cold outreach 10:1. Start with existing investors—your Series A lead should introduce you to 5-10 Series B firms they've co-invested with. Every board member should provide 2-3 introductions. Target firms with thesis alignment—don't pitch generalist Series B firms when you're vertical SaaS.

    Create inbound interest: publish thought leadership, speak at conferences, get media coverage. The Angel Investors Network directory includes growth-stage investors and family offices that occasionally participate in Series B rounds. Cold outreach to 50 firms that yields 2 partner meetings and 1 term sheet is still valuable in a competitive process.

    What Happens If You Can't Raise Series B?

    Pivot to path-to-profitability immediately. Cut burn, extend runway, and prove you can build a sustainable business without additional capital. Some of the best software companies never raised Series B—they got to break-even and scaled from cash flow.

    Alternative capital structures become relevant: revenue-based financing, venture debt, or strategic investor capital. Down rounds happen—if you raised Series A at $30M post-money and can only raise Series B at $25M post-money, take it if you need capital. Dilution is painful but survivable. Running out of runway is terminal.

    M&A becomes the path for many companies that can't raise Series B. The 2 out of 3 failure rate isn't because companies had bad products—it's because they couldn't prove unit economics, market size, or execution capability needed to justify growth-stage institutional capital.

    Frequently Asked Questions

    How much should a startup raise in a Series B round?

    Most Series B rounds range from $15M to $60M according to GrowthList (2026), with the median around $20M-$30M. The amount depends on your burn rate, growth targets, and time to next milestone. Raise 18-24 months of runway minimum.

    What revenue do you need before raising Series B?

    Investors typically expect $5M-$10M in annual recurring revenue with consistent 15-20% monthly growth, per Sheetventure (2026). Below $5M ARR, most institutional Series B firms will pass regardless of other metrics.

    How long does a Series B fundraise take?

    Plan for 3-6 months from first partner meeting to closed round. Strong companies with competitive processes can close in 6-8 weeks. Difficult raises can drag 9-12 months and often fail to close.

    What percentage of startups that raise Series A make it to Series B?

    Only 1 in 3 startups that secure Series A funding ever reach Series B, according to Sheetventure (2026). The majority fail to hit growth milestones or prove unit economics needed for growth-stage capital.

    Do you need to be profitable before Series B?

    No, but you need a credible path to profitability within 12 months of closing the round. Investors want proof you could reach break-even if growth slows or market conditions change.

    What is a good valuation for Series B?

    Median pre-money Series B valuations sit around $100M-$103M according to Carta data cited by GrowthList (2026). Bridge rounds trend slightly lower at $80M-$85M. Strong companies in hot sectors can command $150M+ valuations.

    Should founders participate in their own Series B?

    If you have personal capital and believe in the business, yes. It signals conviction to new investors. But don't over-extend financially—you're already heavily concentrated in company equity through your founder shares.

    What's the difference between Series B and growth equity?

    Series B is typically still venture capital focused on scaling product-market fit. Growth equity comes later (often Series C+) and targets companies with proven business models approaching or past $50M ARR with clear paths to profitability.

    Ready to connect with institutional investors and angel groups actively deploying capital? Apply to join Angel Investors Network and access our network of 50,000+ accredited investors and funding sources.

    Looking for investors?

    Browse our directory of 750+ angel investor groups, VCs, and accelerators across the United States.

    Share
    D

    About the Author

    David Chen